鶹ý

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the 鶹ý’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.

John Streicher gives research talk at Jackson Laboratories

John Streicher, Ph.D., research assistant professor in the College of Osteopathic Medicine, travelled to Jackson Laboratories (JAX) in Bar Harbor, Maine, Friday, October 19, 2012, to speak at the Genetics Interest Group meeting.

Streicher presented a talk titled “Novel Strategies for Drug Discovery and Development,” which explored new strategies for forming molecular signaling profiles of diseases or conditions and discussed a drug discovery approach to fit the profile, yielding potentially better therapeutic results with fewer side effects. He spoke on the search for a kappa opioid receptor functionally selective agonist as well as designing a novel bivalent molecule with dual selectivity for mu opioid receptor and cholecystokinin receptor antagonism.

Streicher met with faculty members of JAX to discuss mutual interests, capabilities of UNE, and collaboration on future research. He also met with the director of Core Services, which could be particularly helpful to researchers at 鶹ýusing mouse models.